Nivolumab for pediatric malignant peritoneal mesotheliomaMelek Yaman, Emel Ünal, Ömer Suat Fitöz et al.|Pediatric Blood & Cancer|2022Cited by 2
Nivolumab for Pediatric Malignant Peritoneal MesotheliomaMelek Yaman, Emel Ünal, Sonay İncesoy Özdemir et al.|Unknown|2022Cited by 0
De novo germline TP53 mutation in a pediatric patient with Li–Fraumeni syndrome and diffuse peritoneal mesotheliomaMelek Yaman, Emel Ünal, Hatice Ilgın Ruhi et al.|Pediatric Blood & Cancer|2024Cited by 0